SCHEMBL1023033

SCHEMBL1023033

O=[N+]([O-])c1ccc(O[C@H]2C[C@H]3CC[C@@H](C2)N3)c(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 9/20 0.61
SLC6A2 P23975 6/20 0.61
SLC6A3 Q01959 6/20 0.61
HSPB1 P04792 3/20 0.42
CYP19A1 P11511 3/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
S1PR4 O95977 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HIF1A Q16665 1/20 0.39
MEN1 O00255 1/20 0.39
PTGES O14684 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
PTGS1 P23219 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1023034 1.00 SLC6A4 (0.61) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1
SCHEMBL1023035 1.00 SLC6A4 (0.61) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1
SCHEMBL1074529 1.00 SLC6A4 (0.61) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1
SCHEMBL22042142 0.84 HSPB1 (0.49) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1
SCHEMBL26644463 0.83 SLC6A4 (0.60) SLC6A4SLC6A2SLC6A3CYP19A1ALDH1A1
SCHEMBL22069557 0.82 CYP19A1 (0.55) HSPB1CYP19A1S1PR4ALDH1A1HIF1A
SCHEMBL26128371 0.82 CYP19A1 (0.52) HSPB1CYP19A1S1PR4ALDH1A1HIF1A
SCHEMBL1021553 0.82 POLB (0.53) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1
SCHEMBL1021552 0.82 POLB (0.53) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1
SCHEMBL1021554 0.82 POLB (0.53) SLC6A4SLC6A2SLC6A3HSPB1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501771-B2 Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments SANOFI (FR) 2013-08-06 US disclosed
EP-1987006-B1 NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
US-20090082391-A1 NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS SANOFI-AVENTIS (FR) 2009-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082391-A1 NOVEL AMINOALCOHOL-SUBSTITUTED ARYLDIHYDROISOQUINOLINONES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS MCHR1, AHR, MCHR2 SLC6A4 752/4885SLC6A2 257/4885SLC6A3 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.